Markets & Finance

BNY Mellon posted record second-quarter revenue of $5.7 billion, up 13% year-over-year, with adjusted EPS of $2.46 beating analyst consensus by 24 cents and a pre-tax operating margin of 39.8%. The bank raised its full-year 2026 revenue growth guidance from approximately 5% to 10–11%, citing broad fee growth, a 20% surge in net interest income, and 419 basis points of GAAP operating leverage. The results offer a concrete measure of institutional fee-pool strength and custody-bank economics at a moment of elevated market activity and higher reinvestment yields.

Truist Financial reports Q2 2026 results on July 17, with consensus expecting $1.08 EPS and $3.63 billion in net interest income, roughly in line with management's own guidance for approximately 1% sequential NII growth. Three peer banks reporting ahead of Truist — M&T Bank, U.S. Bancorp, and Fifth Third — each showed firming net interest margins, low net charge-offs, and accelerating fee income, setting a broadly positive sector tone. The primary variables to watch are whether Truist's net interest margin stabilizes after a 5 basis point decline in Q1, and whether commercial real estate office credit stress has moved from managed to contained.

Dassault Systèmes is reportedly negotiating the purchase of Boston-based life-sciences software firm ArisGlobal from Nordic Capital, a deal that would be the French company's second-largest acquisition after its $5.8 billion Medidata purchase in 2019. The target's LifeSphere platform covers pharmacovigilance, regulatory submissions, and clinical trial management, areas where Dassault currently has no leading product. No agreement has been signed, and the Financial Times, which first reported the talks, noted explicitly that a deal is not certain.

Baker Hughes finalized its all-cash acquisition of Chart Industries on July 16, 2026, paying $210.00 per share and financing the deal through approximately $11.5 billion in new debt. Chart now operates as Baker Hughes' third reporting segment, covering cryogenic equipment, air and gas handling, and lifecycle services across LNG, data-center cooling, and carbon capture markets. The company targets $325 million in annualized cost synergies within three years, though specific EPS guidance and integration cost estimates will not be disclosed until Q3 2026 earnings.

State Street posted total revenue of $4.05 billion in Q2 2026, with fee revenue up 17.2% year-over-year and assets under management growing 23% to a record $6.28 trillion, driven by rising equity markets and $114 billion in net investment management inflows. Net income jumped 56% to $1.08 billion, though the EPS gain of 68% is partly inflated by litigation charges that depressed the prior-year baseline. The results led State Street to raise its full-year fee revenue growth guidance to 12–13% and NII growth to mid-teens, and they outpaced fee growth rates reported the same week by peers BNY Mellon at 11% and BlackRock at 8% organic base-fee growth.

On July 16, 2026, Cross Country Healthcare held a special stockholder meeting to vote on its all-cash acquisition by private equity firm Knox Lane at $13.25 per share, a 31 percent premium to the May 6 announcement-date closing price. The U.S. antitrust waiting period expired June 23 without challenge, leaving stockholder approval as the last substantive closing condition. If approved, the company expects to complete the transaction and delist from Nasdaq within the third quarter of 2026.